RBC Says 'Not Enough Clarity on Near-Term Issues Facing' Endo Health; Cuts Target to $25

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

RBC analyst Shibani Malhotra recommended against buying Endo Health (NASDAQ: ENDP) even though the stock is near a 52-week low. In a research note from earlier, Malhotra said there is not enough clarity on near-term issues facing the company. The largest of these issues is the CEO transition Endo has planned for mid-2013.RBC cut their price target on Endo Health from $29 to $25, citing the uncertainty surrounding the CEO change set for mid-2013. Shares of Endo Health are down more than 4 percent to around $25.20.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!